Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

DYX1C1 polyclonal antibody

  • Catalog # : PAB11520
  • Visit Frequency :
  • Countries :
  • Specification
  • Product Description:
  • Goat polyclonal antibody raised against synthetic peptide of DYX1C1.
  • Immunogen:
  • A synthetic peptide corresponding to human DYX1C1.
  • Sequence:
  • PLQVSDYSWQQTKT-C
  • Host:
  • Goat
  • Theoretical MW (kDa):
  • 48.5, 44, 44.2
  • Reactivity:
  • Human
  • Form:
  • Liquid
  • Purification:
  • Antigen affinity purification
  • Concentration:
  • 0.5 mg/mL
  • Quality Control Testing:
  • Antibody Reactive Against Synthetic Peptide.
  • Recommend Usage:
  • ELISA (1:32000)
    Western Blot (0.5-1.5 ug/mL)
    The optimal working dilution should be determined by the end user.
  • Storage Buffer:
  • In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide)
  • Storage Instruction:
  • Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Note:
  • This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Publication Reference
  • Applications
  • Western Blot (Tissue lysate)
  • Western Blot (Tissue lysate)
  • DYX1C1 polyclonal antibody (Cat # PAB11520) (0.5 ug/mL) staining of human brain (frontal cortex) lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
  • ELISA
  • Application Image
  • Western Blot (Tissue lysate)
  • Western Blot (Tissue lysate)
  • enlarge
  • ELISA
  • Gene Information
  • Protein Accession#:
  • NP_570722.2;NP_001028731.1;NP_001028732.1
  • Gene Name:
  • DYX1C1
  • Gene Alias:
  • DYX1,DYXC1,EKN1,FLJ37882,MGC70618,RD
  • Gene Description:
  • dyslexia susceptibility 1 candidate 1
  • Other Designations:
  • OTTHUMP00000162853
  • RSS
  • YouTube
  • Linkedin
  • Facebook